The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Jesse Novak
Advertisement
Jesse Novak is a bioconjugation scientist at Abzena.
Articles by Jesse Novak
Advertisement
Latest Updated Articles
QbD in the Development of ADCs with PBD Dimer WarheadsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5
